Incyte Corporation - Common Stock — Rendiconto Finanziario (NASDAQ:INCY) | MetaTrader

Apri il grafico completo Full chart

Incyte Corporation - Common Stock

Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.

Notizie

Why Is Agios Pharmaceuticals (AGIO) Up 8.6% Since Last Earnings Report?

JPMorgan says large-cap biotech is back as profits and pipelines fuel upside

Why Is Incyte (INCY) Down 1.8% Since Last Earnings Report?

Here's Why Incyte (INCY) is a Strong Momentum Stock

Here's Why Incyte (INCY) is a Strong Value Stock

Bernstein avvia la copertura di Incyte con dubbi sulla crescita

Why Incyte (INCY) is a Top Growth Stock for the Long-Term

H.C. Wainwright mantiene il target price di Incyte a $135

Incyte Corporation (INCY) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Incyte Stock: Analyst Estimates & Ratings

Incyte collabora con Edison Scientific sull’AI per la scoperta di farmaci

Tempus AI: My Pick For An Oncoming Boom In Demand For Data-Driven Precision Medicine (TEM)